Potential role of serum vitamin D as a risk factor in pediatric acute lymphoblastic leukemia

4Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Vitamin D deficiency/insufficiency (VDD, VDI) is common in children yet limited experience exists on the association of VDD and hematologic malignancies amongst this population. Therefore, this study aimed to compare serum vitamin D levels in children with acute lymphoblastic leukemia (ALL) and controls. Moreover, vitamin D levels is compared in subjects with and without relapse and evaluated as a prognostic factor for relapse-free survival (RFS). Children with newly diagnosed ALL were recruited as case group. Data on demographic variables as well as the dietary habits were collected by interview. In addition, serum 25(OH)D3 was measured. The case group was followed up for 36 months to assess RFS. Overall, 358 subjects were included in the study (n = 169 cases, n = 189 controls). The mean levels of 25(OH)D3 were 28.05 ± 18.87 and 28.76 ± 12.99 in cases and controls, respectively (p =.68). VDD was found in 15.4% (n = 26) and 4.2% (n = 8) of the case and control groups, respectively (p

Cite

CITATION STYLE

APA

Nematollahi, P., Arabi, S., Mansourian, M., Yousefian, S., Moafi, A., Mostafavi, S. N., … Kelishadi, R. (2024). Potential role of serum vitamin D as a risk factor in pediatric acute lymphoblastic leukemia. Pediatric Hematology and Oncology, 41(1), 54–64. https://doi.org/10.1080/08880018.2023.2202687

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free